If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Jun 2015 07:00

RNS Number : 9185Q
4d Pharma PLC
23 June 2015
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

4D Pharma plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Woodford Investment Management LLP ("Woodford")

4. Full name of shareholder(s)  (if different from 3.):iv

Clients of Woodford

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

17.06.15

6. Date on which issuer notified:

18.06.15

7. Threshold(s) that is/are crossed orreached: vi, vii

20%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 GB00BJL5BR07

11,946,086

11,946,086

12,239,586

12,239,586

20.2%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

12,239,586

20.2%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Woodford, as Investment Manager

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Jon Webb

15. Contact telephone number:

01865 809023

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFSEREIVFIE
Date   Source Headline
18th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20207:49 amRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSAdditional Interim Clinical Data
16th Mar 20207:00 amRNSParticipation in Chardan Conference
11th Mar 20209:49 amRNSHolding(s) in Company
11th Mar 20207:00 amRNSHolding(s) in Company
9th Mar 202011:07 amRNSResult of Meeting
21st Feb 20202:25 pmRNSHolding(s) in Company
19th Feb 20202:06 pmRNSPosting of Circular
18th Feb 20206:28 pmRNSResult of Placing
18th Feb 20207:00 amRNSLaunch of Placing
7th Feb 20203:18 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSClinical Update
4th Dec 201911:22 amRNSHolding(s) in Company
29th Nov 201911:19 amRNSHolding(s) in Company
8th Nov 201911:27 amRNSHolding(s) in Company
6th Nov 20197:00 amRNSClinical Observations from MRx0518
5th Nov 20195:36 pmRNSHolding(s) in Company
4th Nov 201912:22 pmRNSHolding(s) in Company
4th Nov 201912:04 pmRNSHolding(s) in Company
17th Oct 201911:17 amRNSHolding(s) in Company
15th Oct 20192:51 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSCollaboration with MSD
30th Sep 20197:00 amRNSInterim Results
27th Sep 201912:23 pmRNSHolding(s) in Company
26th Sep 201911:40 amRNSHolding(s) in Company
23rd Sep 20197:00 amRNSPublication of data on neurodegenerative disease
20th Sep 20191:28 pmRNSHolding(s) in Company
20th Sep 20191:19 pmRNSHolding(s) in Company
20th Sep 201911:20 amRNSHolding(s) in Company
27th Aug 20197:00 amRNSAppointment of NED
25th Jul 20197:00 amRNSOncology Programmes Update
8th Jul 20193:51 pmRNSHolding(s) in Company
8th Jul 20197:00 amRNSClinical Update
1st Jul 20197:00 amRNSChange of Adviser
20th Jun 201910:38 amRNSResult of AGM
3rd Jun 20197:00 amRNS4D presents MRx0518 combination study at ASCO
30th May 20197:00 amRNSDirector/PDMR Shareholding
28th May 20192:50 pmRNSAnnual Report and Notice of AGM
23rd May 20197:00 amRNSDirector/PDMR Shareholding
22nd May 20197:00 amRNSDirector/PDMR Shareholding
21st May 20197:00 amRNSFinal Results
16th May 20197:00 amRNS4D Presents Phase Ib Clinical Data on Thetanix®
13th May 20198:00 amRNSParticipation in Conferences
29th Apr 20197:00 amRNSClinical Update - MRx0518 oncology programmes
14th Mar 20197:00 amRNSDirector/PDMR Shareholding
13th Mar 20199:08 amRNSDirector/PDMR Shareholding
8th Mar 20197:00 amRNSParticipation in Microbiome Conference
29th Jan 20197:00 amRNSPublication of data in connection with MRx0518
7th Jan 20197:00 amRNSCollaboration with MD Anderson Cancer Center

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.